ADM, FutureCeuticals, and H&F Are Riding the Wave of Fiber-Fortified Drinks
If you’re a beverage formulator, the fibermaxxing trend has shifted your job from simple fortification to designing for functional benefits. Hitting a 6–9g claim used to be the finish line. But now the fiber should ferment at the right speed so that GLP-1 users experience less bloating. It must carry polyphenols and other actives to […]
Are Insects and Algae the Future of Pet Food? Here’s the missing link your R&D has been looking for.
42% of pet owners now prioritize spending on high-quality nutrition, fueling interest in organic, natural, and minimally processed pet food. Pet parents are becoming increasingly attentive to their pets’ health. This shift pushes R&D teams to explore gut-health formulations and bioavailable nutrients that improve digestion and immunity in companion animals. With pet obesity rates exceeding […]
Pet Owners Are Demanding GLP-1 in Their Pets’ Food. Here’s Why?
50% of traditional weight-loss programs for pets fail, often because busy pet owners find it hard to stick to strict feeding schedules, or resist those pleading eyes at dinnertime. The reason is quite similar to the weight-control problem many pet owners face. It’s tough to control diet or exercise on a regular basis, especially when […]
Ice cream that reduces weight and 3 other trends you must track in 2026
At first glance, the connection between GLP-1 and ice cream is not obvious. High-protein ice cream itself is still an emerging category, and GLP-1 for ice cream is even newer. Many brands are now asking critical questions: How exactly is demand for ice creams changing? What does satiety-driven indulgence look like? And how are competitors […]
7 Food Trends Lean into Nutrient-dense, Protein-forward and Sugar-conscious Products
F&B experts hardly took notice when GLP-1 drugs first entered the market. “I don’t think it is going to be the wild, dramatic impact being suggested,” remarked Rick Miller, the associate director of food and drink research at Mintel, echoing the broader sentiment that these drugs wouldn’t rattle the food ecosystem. Today, the numbers tell […]
Top Trends in GLP-1 Foods Every Researcher Should Be Tracking Right Now
The rising use of GLP-1 receptor agonists like Ozempic and Wegovy isn’t just a medical trend; it’s also changing the landscape of the food and beverage industry. According to a 2024 survey by Morgan Stanley Research, 59% of individuals on anti-obesity medication are drinking more tap or still water, 66% are consuming less soda and […]
Why Nestlé, ADM, and Others Are Betting Big on GLP-1 Food Innovations?
According to a study by Cornell University, the share of the U.S. population taking GLP-1 drugs increased from 5.5% in October 2023 to 8.3% in July 2024. In prior years, new users taking GLP-1 medications for weight management and diabetes increased from 21,000 in 2019 to 174,000 in 2023, marking a 700% rise. The trend […]
Does GLP-1 Medicine Really Help Fight Addictions or Is This A Placebo?
Patients taking GLP-1 medications for weight loss and blood sugar control reported some surprisingly interesting changes in their habits. They found it easier to resist cravings and cut back on addictive behaviors, particularly around food. “Anecdotally, people with food addiction who find GLP-1s helpful in this regard talk about how the medication turns down the […]
Why Nestlé’s 66% GLP-1 Boost Matters for Every R&D Leader
Key insights: 90% of GLP-1 users now express interest in food products that support their health goals, reflected in their changing shopping habits. GLP-1 users are consuming 127% more high-protein foods and fewer sugary drinks. This shift has pushed the F&B industry to explore natural ingredients that simulate GLP-1 production. Harleen Singh, industry expert at […]
How GLP-1 became the breakthrough multi-organ drug of the decade.
GLP-1 drugs have quickly moved beyond their image as “just weight-loss medicines.” Recent U.S. approvals, Zepbound (tirzepatide) for sleep apnea in 2024, Wegovy (semaglutide) for MASH with fibrosis in 2025, and Ozempic (semaglutide) for reducing the risk of kidney disease worsening, show how these medicines are now being used for a wide range of health […]